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Small,  hydrophilic  molecules,  including most  important  antibiotics  in  clinical  use,
cross the Gram-negative outer membrane through the water-filled channels provided
by porins. We have determined the X-ray crystal structures of the principal general
porins  from three  species  of  Enterobacteriaceae,  namely  Enterobacter  aerogenes,
Enterobacter  cloacae  and Klebsiella  pneumoniae and  determined  their  antibiotic
permeabilities as well as those of the orthologues from Escherichia coli. Starting from
the  structure  of  the  porins  and  molecules  we  propose  a  physical  mechanism
underlying transport and condense it in a computationally efficient scoring function.
The scoring function shows good agreement with in-vitro penetration data and will
enable  the  screening  of  virtual  databases  to  identify  molecules  with  optimal
permeability  through porins and help to guide the optimization of antibiotics  with
poor permeation.
Keywords: bacteria, antibiotics,  rational design, porins structure, transport, scoring
function. 
Drug-resistant bacterial infections are a significant public health issue globally and
without  concrete  actions  and  innovation  there  is  a  threat  of  returning  to  ‘pre-
antibiotic’  era  1–3.  Gram-negative  bacteria  in  particular  have  significant  intrinsic
resistance to many classes of antibiotics owing to their outer membrane (OM) which
imposes a physical barrier that limits the range of molecules that are taken up into the
bacteria  4–6.  This  has  been recognized as  a  contributing  factor  to  the  difficulty  in
finding potent new antibacterial agents acting against these organisms 7–9. Analyses of
compounds  with  antibacterial  activity  has  shown  that  marketed  antibiotics,  and
analogues,  that  act  against  Gram-negative  bacteria  have  restricted  ranges  of
physicochemical  properties  (e.g.  size  and  lipophilicity),  although  wider  ranges  of
properties have been observed for compounds that act via non-specific mechanisms,
e.g. membrane disruption  10–12. The emphasis on molecular properties alone was not
sufficient to provide clear determinant rules for transport. In part, this is because such
approach does  not  consider  the  individual  mechanisms  of  translocation  across  the
outer  membrane  and thus  blurs  the  details  of  distinctly  different  transport  routes.
Many antibiotics acting against Gram-negative bacteria are polar molecules and most
exploit the water-filled channels provided by outer-membrane porins (OMP) to enter
the cell  5,6. The transport of β-lactams through the general porins of Escherichia coli
has long been used as a model system to investigate the outer-membrane translocation
of hydrophilic molecules. Transport has been studied by measuring influx rates into
intact  cells  13–15 and by monitoring liposome swelling  using reconstituted,  purified
proteins  16. The interactions between porins and antibiotics have been studied using
electrophysiology  and  all-atom  molecular  dynamics  simulations  to  provide  a
molecular description of the translocation events 17–19. Recent efforts have been made
to construct a quantitative model of drug accumulation into E. coli cells considering
both influx and efflux14,20,21. In this picture, porins function as non-specific channels
for the passive diffusion of drugs across the OM and steady-state intracellular drug
concentrations are balanced by the specificity and efficiency of transmembrane efflux
pumps20,22–24.
The  porins  of  Enterobacteriaceae  share  high  levels  of  sequence  identity  with  the
archetypal OmpF porin of  E.coli.  The channel has an hourglass shape  25,26,  with a
narrow constriction region (CR) and segregation of charged residues on opposite sides
of the pore that creates a strong transverse electric field across the CR 27–29. Although
there  is  high  overall  sequence  similarity,  small  changes  in  the  CR are  known to
perturb small molecule permeation  30 and therefore specific knowledge of structural
details of the individual channels, and how these influence transport, is essential. 
Here we determined the crystal structures of OmpF and OmpC orthologues from three
clinically relevant31–33 Gram-negative species, namely  E. cloacae, E. aerogenes  and
K. pneumonia, and combined these with the known  E. coli structures to provide a
substantial  basis  for  defining  channel  properties.  We have used  a  set  of  β-lactam
antibiotics, representing the most used classes, including analogues with a range of
shapes and sizes, to provide a test set for investigating pore permeability. We studied
the interaction and transport of this test set with the eight structurally characterized
enterobacterial porins. Combining this data set with molecular dynamics simulations,
we have defined the physical mechanism underlying transport and condense it into a
scoring function, which accurately predicts permeability through porins. Moreover,
we  have  shown  that  applying  this  scoring  function  to  a  small  set  of  molecules
unrelated to the training set  provides results that are consistent with the published
whole cell bacterial accumulation data10.
RESULTS
The porin architecture 
We  determined  the  crystal  structures  of  OmpF  and  OmpC  orthologues  from
Enterobacter aerogenes (Omp35 and Omp36), Enterobacter cloacae (OmpE35) and
Klebsiella  pneumoniae (OmpK35  and  OmpK36).  The  structure  of  E.  cloacae
OmpE36 has been solved recently 34, and the structures of the E. coli orthologues are
also known 25,26. The porins share on average ~70% sequence identity (Supplementary
Fig. 1,  Supplementary Table 1). As expected, the overall structures (Supplementary
Fig. 2) are very similar and consist of trimers of sixteen-stranded β-barrels, each with
a CR halfway down the central  axis formed by the extracellular  loop L3 (Fig.  1,
Supplementary Fig. 2). The segregation of charged residues on opposite sides of the
internal walls creates a strong transverse electric field that plays an important role in
stabilizing the desolvated form of polar molecules, thereby aiding their translocation
27–29. The acidic residues from the CR of OmpF (Fig. 1b), D113, E117, D121 from L3,
are conserved in all structures (Supplementary Fig. 1), while some differences were
found for the residues forming the basic ladder on the opposing face,  presumably
modulating the transverse field in the different orthologues (Supplementary Fig. 1). 
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Figure 1 | The Major Outer Membrane Porin F/C architecture. The main features
of  the  OmpF/OmpC  orthologues  are  depicted  for  OmpF  (E.coli):  a,  trimeric
arrangement depicted as ribbon (Chimera software 35), b, top view of the trimer with
the loop L3 highlighted in orange balls and sticks,  c, for one of the monomers the
empty lumen (calculated from all-atom simulations) is highlighted as a purple surface
and the CR is indicated. d,  The main charged residues are depicted as balls and sticks
and coloured according to their charge, e, top-view of d.
Structural determinants for permeability
We modelled each porin in trimeric state embedded in a pre-equilibrated phospholipid
bilayer  (POPC)  with  a  200  mM  KCl  bath  solution  and  performed  all-atom  MD
simulations.  We  calculated  the  average  geometrical  cross  section  (Fig.  1c,
Supplementary  Fig.  3a-c)  and  the  average  internal  electrostatic  field  28
(Supplementary Fig. 3d-f) and potential (Supplementary Fig. 3g-i) from 600ns-long
trajectories.  As  expected,  the  pore  radii  decrease  dramatically  in  the  CR
(Supplementary Fig. 3a-c). The intensity of the internal electric field is strongest at
the  CR  and  perpendicular  to  the  axis  of  diffusion  (transversal  component)
(Supplementary Fig. 3d-f). In contrast, the longitudinal component is negligible in the
CR  for  all  structures.  Despite  the  structural  similarities,  we  found  substantial
differences  between the calculated  electric  fields.  OmpC and orthologues  Omp36,
OmpE36, OmpK36 possess a smaller pore radius, lower conductance, and a lower
intensity of the transversal electric field compared to OmpF and orthologues Omp35,
OmpE35,  OmpK35  (Table  1).  Further,  the  OmpC-like  proteins  are  more  cation-
selective than OmpF-like (Table 1).
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OmpF 4.0±0.2 1.33 3.1±1.1 25.2±0.56 -1.3±0.06
OmpC 2.9±0.1 2.20 2.8±1.1 15.6±0.39 -0.5±0.03
Omp35 3.9±0.5 1.72 3.6±1.7 22.8±0.78 -0.5±0.11
Omp36 3.0±0.2 2.22 3.0±1.3 14.9±0.01 -0.7±0.03
OmpE35 4.4±0.2 1.42 3.1±1.3 25.8±1.00 -1.0±0.08
OmpE36 3.0±0.2 2.13 3.1±1.6 22.3±0.64 -1.5±0.04
OmpK3
5 
4.4±0.4 1.36 3.6±1.4 14.9±0.4 -0.6±0.06
OmpK3
6 
2.5±0.2 1.68 2.8±1.4 19.1±0.36 -1.2±0.09
Table  1  |  OmpF/C orthologues physical  properties.  Measured  conductivity  and
selectivity  from single-channel  electrophysiology  (SI Materials  and Methods);  the
average values from the molecular dynamics runs: the minimum radii in the CR/, the
average transversal electric field in the CR (Ep), and the average electrostatic potential
in the CR (Vp).
Experimental determination of permeability 
Liposome swelling assay (LSA) was selected to measure permeability of porins. The
permeability  of  nine  clinically  relevant  antibiotics  (Fig.2,  Supplementary  Table  2)
through eight distinct channels (Fig. 3) provides a dataset comprising 72 independent
measurements.  Each  set  of  antibiotics  is  normalized  with  respect  to  glycine
permeability for a given porin.
The LSA results for OmpF permeability are consistent with previous LSA data 16 and
with influx rate measurements in intact cells 13–15 .
Figure  2  | Molecular  properties  of  selected  clinically  relevant  antibiotics.
Molecular structure of the nine clinically relevant antibiotics used in the study. Each
antibiotic is represented as a licorice model with its total dipole moment depicted as
an orange arrow. Charged groups at pH 7 are highlighted in red (negative) and blue
(positive). The charged groups, the component of the dipole moment perpendicular to
the long axis (Dxy, in Debye) and the molecular weight are reported for each molecule.
As might  be expected  from the respective pore sizes (Table  1),  molecules  have a
higher permeability through OmpF orthologues than through OmpC orthologues.  The
zwitterionic molecules,  meropenem (MEM), imipenem (IMI), and cefepime (FEP),
exhibited high relative permeabilities (40-80% of glycine permeability) for all porins.
Ampicillin (AMP) had lower relative permeability, resembling more the negatively
charged  molecules  ceftazidime  (CAZ),  cefotaxime  (CTX),  piperacillin  (PIP)  and
ticarcillin  (TIC),  which  displayed permeabilities  ranging from 0-40%. In contrast,
ertapenem (ETP),  which also has  a  net  negative  charge,  showed elevated  relative
permeability,  similar  to  that  of  zwitterionic  molecules,  except  for  OmpE35  and
OmpE36 (Fig. 3). Overall,  MEM showed the highest relative permeability through
porins (~60%) while PIP (larger size and negatively charged) and TIC (dianionic) had
the lowest. 
Figure  3  | Relative  permeability  of  β-lactams  through  OmpF/C  orthologues.
Permeation  rates  determined  from  LSA  experiments.  Data  are  displayed  for  the
relative permeability of nine antibiotic molecules, e.g. ampicillin (AMP), ticarcillin
(TIC),  piperacillin  (PIP),  ertapenem (ETP),  imipenem (IMP),  meropenem (MEM),
cefotaxime (CTX), cefepime (FEP) and ceftazidime (CAZ), through porins of E. coli
(OmpF and OmpC), E. aerogenes  (Omp35 and Omp36),  E. cloacae (OmpE35 and
OmpE36) and  K. pneumoniae (OmpK35 and OmpK36), normalized with respect to
glycine (GLY), which is set to 100%.
The scoring function for permeability: connecting structure to transport 
In  order  to  quantify  antibiotic  permeability  through porins,  we need  a  theoretical
model for permeability to understand  how the molecular-scale properties of porins
control the macroscopic flow of molecules.  If we treat the antibiotic  translocation
process as a one-dimensional diffusion-drift problem 36,37, the molecular flux through
the channel  follows Fick’s  law,  J =- NaPS0Dc,  where Δc is  the difference  of the
antibiotic molar concentrations, S0 is the geometrical cross section at the mouth of the
channel and Na is the Avogadro constant. The permeability coefficient P, reflects the
ability of a certain molecule to translocate through the channel. Hence, its calculation
requires  the  knowledge  of  the  pore-molecule  interaction  energy  along  the  whole
length  of  the pore (Materials  and Methods).  This  interaction  energy,  U(z)  can  be
determined from all-atom MD simulations, but its determination is computationally
expensive even when applying enhanced sampling techniques  38, prohibiting virtual
screening of large compound libraries. Nevertheless, as previously reported29 the main
contribution  to  the  pore-molecule  interaction,  U(Z),  comes  from  the  free-energy
barrier located in the CR. Therefore, the permeability coefficient can be approximated
to 
P =Deff
DL e
- 1kBT
UCR
, where Deff is the effective diffusion constant in the CR and UCR is
the free-energy barrier for the permeating molecule in the CR, ΔL the length of the
CR, kB the Boltzmann constant, and T the temperature. Within this approximation,
the logarithm of the permeability coefficient can be directly connected to the free-
energy  barrier  in  CR  only29,37,  
ln(P)=- 1kBT
UCR +const
.  Thus,  we  can  define  a
scoring function for permeability from the knowledge of a few accessible molecular
parameters that can be directly calculated from MD (Materials and Methods: Scoring
Function derivation and calculation protocol):
Sc =ln(P)=a×Usteric +b ×(Qm×Vp)+g×(Dm×Ep)+d        (1)
The first term accounts for the size exclusion problem inside the CR (Fig. 4), which
depends on both the average size of the pore (minimum cross-section) and molecule
(minimum projection area). This entropic term determines a barrier for molecules and
controls spontaneous uptake. The second and the third terms of Eq.1 account for the
electrostatic  interactions  of  the  diffusing  molecule  with  the  pore,  through  the
electrostatic  potential  (Vp)  and electric  field (Ep),  interacting  respectively  with the
charge Qm and the dipole Dm of the molecule. These two terms modulate the total
barrier for permeation (Fig. 4) and can decrease the effect of the steric barrier. In our
model the selectivity of these porins for cations arises from their interaction with the
negative  electric  potential  inside  the  CR.  It  should  be  noticed  that  although  the
mechanism is general, an entropic barrier modulated by electrostatic interactions, the
same  molecule  will  exhibit  different  permeability  rates  in  different  pores.  Pore
structural changes are reflected in changes in the minimum cross-section area and
electrostatic properties that must be calculated from the MD simulation of the pore in
a realistic environment.
OM CR
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Figure  4  | Modulation  of  the  total  barrier  for  permeation.  a, All-atom
representation of the permeation of a small molecule through one OmpF (ribbons)
monomer. b, Schematic  representation  of  the  relevant  descriptors  for  the  scoring
function. The molecule is represented by its size (black oval) and charge distribution,
while the porin is represented by its hourglass shape and charge distribution in the
CR.  c, Energetic  decomposition  of  the  total  free-energy  barrier  faced  by  small
molecules during permeation through porins.
The standard LSA technique also assumes Fick’s law for the substrate flux 39, hence
the  total  permeability  of  a  substrate  a is  proportional  to  the  corresponding
permeability  coefficient.  Because  experimentally  we  have  access  to  relative
measurements: Pexp (a )=
P ( a )
P ( glycine )
, the shift δ in Eq.1 can be redefined including the
permeability of glycine.
To obtain the parameters for the scoring function,  Eq.1, we applied standard least
square method using α, β, γ, and δ as fitting parameters to reproduce the measured
LSA data of Fig. 3. The results shows an excellent correlation, r=0.86, with a root
mean square error (RMSE) of 0.47 (Fig. 5a). The analysis of the results grouped by
charge (Fig. 5b), size (Fig. 5c) or transversal dipole moment of each molecule (Fig.
5d) allows several general observations. (i) Anionic molecules are disfavoured due to
electrostatic repulsion by the porins, which to varying degrees are cation selective
(Fig.  5.b).  (ii)  The  size  of  the  molecule,  defined  as  its  minimal  projection  area,
correlates with permeability (Fig. 5c). (iii) The magnitude of the transverse dipole
moment of a molecule Dxy (with respect to the main inertia axis of the molecule) is
directly correlated with permeability (Fig. 5d). The alignment of the transversal dipole
moment  of  the  molecule  to  the  transversal  electric  field  of  the  pore  is  always  a
favorable interaction (Eq.1), hence it decreases the barrier and increases molecular
permeability.  Although,  from  Fig.  5d  the  correlation  of  Dxy  looks  weak  when
confronted with the charge or the size (Fig. 5b,c), in some cases, like ertapenem, it
can  compensate  for  the  charge  penalty  imposed  by  the  selectivity  of  the  pore.
Ertapenem has a net negative charge (Supplementary Table 2) and its size (~57  Å2) is
comparable to that of the negatively charged cefotaxime (~59 Å2) and zwitterionic
cefepime (~58 Å2). However, its permeability is similar to cefepime permeability and
higher  than  that  of  cefotaxime,  since  its  charge  distribution  shows  the  biggest
transversal  dipole  moment  (~22.2  Debye,  Supplementary  Table  2)  of  the  set  of
antibiotics considered.
Figure 5 | Measured vs.  predicted permeability  of  antibiotics  through Gram-
negative bacterial porins.  Correlation between modelled permeability and relative
permeability estimated in liposome swelling experiments. Modelled permeability vs.
experimental permeability  is shown with respect to porin and compounds identity:
ampicillin (AMP), ticarcillin (TIC), piperacillin  (PIP), ertapenem (ETP), imipenem
(IMP),  meropenem  (MEM),  cefotaxime  (CTX),  cefepime  (FEP)  and  ceftazidime
(CAZ),,  a,  and  with  respect  to  several  molecular  properties,  namely  charge,  b,
molecule size, c, and transversal dipole, d.
To test the assumption that glycine has the same permeability in all pores, we include
a shift parameter (δi) and fit it separately for each pore. Moving from four to eleven
fitting parameters, we obtained r=0.88, with a RMSE of 0.43. This small variation
supports our initial assumption.
While our data suggests that performing LSA experiments with the same system for
charged and uncharged molecules gives reasonable results (Fig. 5), the use of LSA
with charged molecules can in principle pose problems due to the movement of the
respective  counter  ions  16.  We  therefore  cross-validated  the  scoring  function  for
charged  molecules  using  single-molecule  electrophysiology  data  (Supplementary
Table  3).  Assuming  the  barrier  to  enter  the  current-blocking  state  is  similar  (or
‘proportional’)  to  the  barrier  for  permeation,  the  logarithm  of  the  measured
association  rate  (log(kon_ave))  can  be  correlated  to  the  log(P).  The  correlation
coefficient for scoring function (with the α, β, γ, and δ previously fitted to LSA data)
versus log (kon_ave) is 0.75 (Supplementary Figure 6), validating LSA data for charged
molecules.
Testing the scoring function on bacteria:  β-Lactam activity  and flux through
porins
In order to validate our scoring function and the LSA results with in vitro antibacterial
data,  the  ability  of  β-lactams  to  cross  the  OM  through  the  different  porins  was
determined  using  time-kill  assays.  We  selected  the  cephalosporins  cefepime  and
ceftazidime,  as  readily  and poorly  permeating  substrates  respectively  (Fig.  6).  As
expected ceftazidime exhibited faster killing on cells expressing OmpF-like (~0.01%
survival  at  t  =  150 min,  almost  no survival  at  t  =  180 min)  than  it  did on cells
expressing OmpC-like porins (~1-10% survival at t= 150 min and 180 min) ( Figure
6,  left  panel).  Cefepime,  on  the  other  hand,  exhibited  similar  killing  kinetics
regardless the type of porin expressed (~0.001-0.1% survival at t = 150 min, almost
no survival at t = 180 min) (Figure 6, right panel). This is generally consistent with
the scoring function prediction, where the zwitterionic cefepime is expected to have
better permeability than for the anionic and larger ceftazidime. 
The  scoring  function  permeability  predictions  are  also  in  agreement  with  results
reported  in  literature  14,15,40.  For  example,  it  correctly  describes  the  increased
permeability of ampicillin with increasing salt concentration in OmpC 15 and not in
OmpF (Supplementary  Figure  7a,b).  It  is  interesting  to  note  that  this  behavior  is
common to all the considered zwitterionic molecules (Supplementary Figure 7a) due
to  the  screening  of  the  internal  electric  field  of  OmpF  with  increasing  salt
concentration 28 while the OmpC internal electric field remains unaltered. The reason
for this is that the water polarization-based method  28, used to calculate the internal
electric field of the channel, explicitly takes into account the media and hence its salt
concentration.  Conversely,  this  behavior  is  not  observed  for  negatively  charged
molecules  (Supplementary  Figure  7c),  where  the  screening  of  the  electrostatic
potential, upon ion addition, plays a larger role at low concentrations than the effect of
the  electric  field.  Further,  the  scoring  function  predicts  a  higher  permeability  for
ampicillin  through  OmpF  and  OmpC,  than  benzylpenicillin  at  different  salt
concentrations (Supplementary Figure 7d). This result is in agreement with previous
literature  14 (Supplementary  Figure  7d,  black  dashed  line)  and  highlights  the
importance of the presence of a positive group in the scaffold  40. The addition of a
positive  charge  to  the  anionic  benzylpenicillin  to  obtain  ampicillin  alters  the
electrostatic  properties  making  ampicillin  zwitterionic  and  increasing  its  dipole
moment (from ~18 Debye to ~34 Debye) leading to increased permeability, although
ampicillin (~50 Å2) has a larger minimal projection area than benzylpenicillin (~46
Å2).
Figure  6 | Influence  of  porin  expression  on  the  rate  of  β-lactam  antibiotic
activity.  Percentage  decrease  in  cfu/ml  of  K12ΔFC cultures  expressing individual
porin orthologues upon exposure to inhibitory concentrations of ceftazidime (CAZ
0.25 µg/ml, left panel) or cefepime (FEP, 0.125 µg/ml, right panel). Experiments were
repeated at least three times.
Testing the scoring function on bacteria: non β-lactam scaffolds
We also tested the performance of the scoring function predictivity with some non β-
lactam  molecules  (not  included  in  the  training  set),  using  the  recently  published
whole-cell accumulation data  10. Although, accumulation studies do not necessarily
correlate  directly  with  outer  membrane  permeability  (e.g.  due  to  inner  membrane
permeability or efflux), we selected a subset of molecules whose properties suggested
that  they  were  likely  to  enter  the  cell  through  porin-mediated  transport
(Supplementary Figure 8). The scoring function presented here was able to correctly
describe changes in permeability caused by chemical substitutions that significantly
altered charge, size, shape (linearity) and dipole moment (Supplementary Figure 8,
Supplementary Table 4) and correlated with accumulation data  10. Molecules with a
net positive charge (1,2,3 in Supplementary Figure 8) showed higher accumulation
and have better permeability according to our scoring function (Supplementary Figure
8) than their neutral versions (13,14,15 in Supplementary Figure 8). This is due to the
favourable  interaction  of  the  net  positive  charge  with  the  negative  electrostatic
potential in the CR. According to accumulation data 10, molecule 19 is an example of
how  globularity  affects  negatively  accumulation  (Supplementary  Figure  8,
Supplementary Table 4). In our scoring function globularity is taken into account in
terms of the minimal projection area. Molecule 19 has a high minimal projection area;
hence  we predict  a  low permeability  (Supplementary  Figure  8).  Due to  the  same
reason, molecule 3 is predicted to have a lower permeability than molecules 1 and 2,
reproducing  the  trend  of  the  accumulation  data  (Supplementary  Figure  8,
Supplementary Table 4). The correlation of the whole cell accumulation data with the
predictions  of  the  scoring  function  on  molecules  completely  unrelated  to  the  β-
lactams suggests the potential utility of the scoring function despite the small size and
β-lactam-focus of the training set.
DISCUSSION
General  porins  are  the  principal  route  of  entry  for  polar  antibiotics  such  as
fluoroquinolones,  penicillins,  cephalosporins  and  carbapenems  17–19 in
Enterobacteriaceae.  Previous  understanding  of  molecular  transport,  based  on
electrophysiological  measurements  and simulations,  identified  the  CR as  the  rate-
limiting  step  for  transport  19,29.  With  the  identification  of  new  crystallographic
structures  from  different  porins  of  Enterobacteriaceae  we  established  the  key
structural features of the CR (electric field, electrostatic potential and size) in general
porins. While previous studies have been focused in the exploration of the chemical
space of molecules only, here we included the exploration of porin diversity via the
structural determinants. This has allowed us to analyze experimental transport data in
term  of  pore-molecule  interaction  terms  and  validate  the  underlying  molecular
mechanism  37.  The  proposed  scoring  function  is  based  on  well-defined
physicochemical  properties  coming  from main  porin  features:  an  entropic  barrier,
related to the hourglass shape of porins, modulated by the electrostatic interactions of
the molecule in the charge-segregated CR of the porin. As it is designed, a compound
is simply described by its partial atomic charges (to determine charge and dipole) and
size (minimal projection area), hence, there is no dependence on specific chemical
groups. This should allow general use of the scoring function as these parameters are
straightforward to calculate, even if they are not as familiar as other descriptors such
as molecular weight or clogP. 
Our scoring function reproduces the measured permeability differences between two
related molecules, benzylpenicillin and ampicillin  14, confirming the importance of a
positively-charged group in the scaffold to  enhance  permeation  10 (Supplementary
Figure  7d).  Moreover,  it  correctly  accounts  for  the  modulation  of  ampicillin
permeation  through  OmpF  and  OmpC  as  a  function  of  media  osmolarity  15
(Supplementary Figure 7a,b), thanks to the water polarization-based method 28 used to
calculate the internal electric field of the channel, which explicitly takes into account
the  media  and  hence  its  salt  concentration.  The  importance  of  the  transversal
component  of  the  dipole  moment  with  respect  to  the  main  axis  of  inertia  of  the
molecule  to  aid  permeation  is  also  highlighted.  As  observed  for  ertapenem  and
ampicillin vs. benzylpenicillin,  the introduction of a positive group in the scaffold
increases permeability due to the increase of the transversal electric dipole moment. 
Although as mentioned accumulation studies do not necessarily correlate directly with
porin permeability, we were able to rationalize with a robust molecular mechanism
(Fig. 4) the empirical rules proposed by Richter et al. 10 to enhance accumulation into
Gram-negative cells. The non-globularity of molecules required for accumulation is
related to the size exclusion problem of the CR of these porins. This aspect is taken
into account into the scoring function by using the minimal projection area of the
molecule instead of the more widely used molecular weight  7. Further, the observed
higher accumulation conferred by addition of a primary amine 10 is directly related to
the  intrinsic  negative  electrostatic  potential  calculated  inside  CR (Fig.  3g-i).  This
approach  has  been  used  to  modify  antibiotics  to  significantly  increase  their
intracellular accumulation in Gram-negative bacteria 10,40. However, it is notable that
many  marketed  compounds  that  transit  through  porins  41,42 are  zwitterionic  at
physiological  pH.  While  this  may  lead  to  lower  absolute  accumulation  43 inside
bacteria, these antibiotics have been selected not only for optimum penetration (i.e.
activity)  balanced with  appropriate  drug-properties  (pharmacokinetics,  safety,  etc.)
7,43–45.  Based  on  the  results  presented  here,  our  model  is  able  to  accurately  rank
molecules in terms of their permeability thus making it feasible to use it to optimise
potentially useful series of novel antibiotics. 
Our approach offers a different perspective for predicting permeability through the
OM of Gram-negative  bacteria:  instead of searching for an energy minimum or a
binding  site  obtained  by  docking  procedures,  it  assesses  how  a  molecule  can
compensate the inherent entropic barrier of pores. This approach provides a set of
molecular determinants that are easily calculated: size, dipole moment and net charge.
The  molecular  mechanism  only  depends  on  porin  structural  features,  hence  the
derived  scoring  function  can  be  readily  extended  to  porin  variants  occurring  in
resistant  strains  selected,  for  example,  by  exposure  to  carbapenems,  to  provide
molecular insights into the development of resistance 19. Moreover, this procedure is
computationally efficient and can potentially be used to screen large virtual libraries
to identify new scaffolds with good permeation through porins. This approach will
allow computational approach to improve antibiotics with poor porin permeation and
define scaffolds with optimal porin permeability that might be used as starting point
for developing new antibiotics.
METHODS
X-Ray Crystal  Structure  Determination  of  E.  cloacae OmpE35,  OmpE36,  K.
pneumoniae OmpK35, OmpK36 and E. aerogenes Omp35 and Omp36
Genomic DNA from E. cloacae  (ATCC 13047) and  K. pneumoniae (ATCC 43816)
was obtained from Basilea Pharmaceutica International Ltd. The genes including the
signal sequence was amplified using PCR with the following primers: 
OmpE35_for 5’-GCGCCATGGGCATGAAGCGCAATATTCTG-3’, 
OmpE35_rev 5’-CTAGTCTAGATTAGAACTGGTAAACCAGAC-3’, 
OmpE36_for 5’-GCGCCATGGGCAAAGTTAAAGTACTGTC-3’, 
OmpE36_rev 5’- CTAGTCTAGATTAGAACTGGTAAACCAGAC-3’, 
OmpK36_for 5’-GCGCCATGGGCAAAGTTAAAGTACTGTC-3’, 
OmpK36_rev 5’-CTAGTCTAGATTAGAACTGGTAAACCAGGC-3’, 
OmpK35_for 5’-CTAGGAATTCACCATGATGAAGCGCAATATTCTGGCA-3’, 
OmpK35_rev 5’-CTAGTCTAGATTAGAACTGGTAAACGATACCCACG-3’.
The PCR products were digested with NcoI and XbaI or EcoRI and XbaI for ompK35,
and ligated with the pBAD2446 or pB22 vector47 for  ompK35 under the control the
arabinose-inducible  promoter.  The  ligated  product  was  electroporated  into  DH5α-
competent  cells  and  plated  on  LB-ampicillin  plates  (100  μg/mL) for overnightg/mL)  for  overnight
incubation at 37 °C. Screening for positive clones was done using colony PCR, and
clones were confirmed by DNA sequencing (Eurofins MWG). Porin-deficient E. coli
BL21  (DE3)  Omp8 competent  cells  (ΔlambB ompF::Tn5 ΔompA ΔompClambB  ompF::Tn5  ΔlambB ompF::Tn5 ΔompA ΔompCompA  ΔlambB ompF::Tn5 ΔompA ΔompCompC)48 were
transformed with one of the positive clones, and protein was expressed using 0.1%
arabinose  for  induction  (37  °C,  3  h).  The  cells  were  harvested  by  centrifugation
[1,914 × g for 30 min (Avanti J-26 XP Centrifuge, Beckman Coulter Inc.)] and lysed
with  a  cell  disrupter  (0.75  kW;  Constant  Systems;  one  pass  at  23  kpsi).  Total
membranes  were  collected  by  ultracentrifugation  using  a  45  Ti  rotor  (Beckman
Coulter Inc.; 45 min; 42,000 rpm). The resulting membrane pellet was extracted twice
with  0.5%  N-lauroylsarcosine  (sarkosyl)  detergent  (in  20  mM  HEPES,  pH  7.5)
followed by ultracentrifugation using a 45 Ti rotor (Beckman; 30 min, 42,000 rpm) to
solubilise and remove inner-membrane proteins, followed by an overnight extraction
at 4 °C in 1% lauryldimethylamine-oxide (LDAO) in 10 mM HEPES, 50 mM NaCl
(pH 7.5) to solubilise the OMPs (OMP extraction for OmpK35 was done using 3%
eluent  for  only  one  hour  unlike  the  rest).  LDAO  extraction  was  followed  by
ultracentrifugation  using  a  70  Ti  rotor  (Beckman;  30  min,  50,000  rpm)  and  the
supernatant was subjected to Resource Q anion-exchange chromatography in 0.2%
LDAO at  pH 7.5 (10 mM HEPES, 50 mM NaCl).  After  elution,  the protein was
further purified by gel-filtration chromatography in 10 mM HEPES, 100 mM LiCl,
0.4% C8E4 (pH 7.5). The purified protein was concentrated and crystal trays were set
up at 10 mg/mL.  The crystal hits obtained in each case were optimised to obtain
good-quality  crystals  (see  Supplementary  Table  5).  Crystals  were  harvested,
cryoprotected, harvested with glycerol (~20%), and flash- frozen in liquid nitrogen.
X-ray diffraction  data  were collected at  the Diamond Light  Source and processed
using  XDS49.  The  crystal  structure  was  solved  by  molecular  replacement  using
MolRep50 with following search models,  E. coli OmpC with PDB code 2J1N (for
OmpE36),  K. pneumoniae OmpK36 with PDB code 1OSM (for OmpK36),  E. coli
OmpF with PDB code 2OMF (for OmpE35) and E. coli OmpF with PDB code 4GCP
(for  OmpK35).  The  refinement  was  done in  Refmac550, and  Coot51 was  used  for
model (re) building.
Codon-optimized  genes  encoding  for  Omp35 (ATCC 15038)  and Omp36 (ATCC
13048) E. aerogenes were ordered from DNA2.0 (California, USA) and cloned into a
pTAMAHisTEV ampicillin-resistant vector and transformed in porin-deficient E. coli
BL21 (DE3) Omp8 250 ml of cell culture in LB containing 100 μg/mL) for overnightg ml-1 ampicillin was
incubated at 37 °C and shacked at 200 RPM overnight. 10 ml of the overnight culture
were used to inoculated 12x 1 L LB containing the same amount of ampicillin and
grown at 37 °C until OD600 ~ 0.6. Cells were then induced with 0.4 mM isopropyl β-
D-thiogalactopyranoside (IPTG) and the temperature decreased to 25 °C. The cells
were let  to  grow 16 hours  and then  harvested  by centrifugation  at  6,200 g  (JLA
8.1000 rotor, Beckman Coulter). Cell pellets were re-suspended in lysis buffer; 50
mM Na3PO4 pH 7.4, 250 mM NaCl 10% (v/v) glycerol, 20 μg/mL) for overnightg ml-1 DNAse, 100 μg/mL) for overnightg ml-
1 lysozyme (both Sigma-Aldrich) and EDTA-free protease inhibitor cocktail (Roche).
Cells were lysed by two passes through a chilled cell disruptor at 30 kpsi. Cellular
debris was removed by centrifugation at 10,000 g (JA 25.50 rotor, Beckman Coulter).
The total membrane fraction was collected by ultracentrifugation at 100,000 g (50.2
Ti rotor, Beckman Coulter) at 4 °C for 1 hour. The membrane was solubilized with
7% (v/v) Octyl-POE and left  stirring at  4°C overnight.  Soluble material  was then
recovered by ultracentrifugation at 4 °C for 1 hour. The supernatant containing the
solubilized protein was incubated with 5ml of Ni-NTA resin (Qiagen, UK) and 10
mM imidazole pH 8 at 4 °C for 2 hours. The resin was then washed with 10 CV of
washing buffer; 50 mM Na3PO4 pH 8, 250 mM NaCl, 1% (v/v) Octyl-POE (Bachem)
and 30 mM imidazole pH 8. The protein was eluted with the same buffer containing
250 mM imidazole. Consecutively, 1 mg of His6-tagged TEV protease was added to
the eluted protein and dialyzed in SnakeSkin tubing (Thermo Scientific)  against  a
buffer  containing  10 mM imidazole  at  4  °C overnight.  The  dialyzed  sample  was
passed through a 0.45 μg/mL) for overnightm syringe filter and applied to a 5 ml His-trap column (GE
Healthcare).  The cleaved protein was collected from the flow-through fraction and
further purified by gel filtration using a 16/ 60 Superdex 200 pg (GE Healthcare)
equilibrated with 2 CV of a buffer containing 10 mM Tris-HCl, 150 mM NaCl and
0.45%  (w/v)  C8E4  (Bachem).  The  protein  was  concentrated  to  10  mg  ml-1 for
crystallization.  Purity  and  integrity  were  monitored  on  SDS-PAGE  (NuPAGE,
Invitrogen) and mass spectrometry. Different commercial screens were used for initial
trials. When required hits were optimized by hanging-drop vapor diffusion technique.
Crystals  were  harvested  and  cool  flashed  in  liquid  nitrogen.  Ethylene  glycol  was
frequently used as cryoprotectant. Listed below are the crystallization conditions that
gave the crystals  used for data  collection.  Data were collected at  the Synchrotron
Light Source and processed using Miosflm52 and scaled with SCALA53. MR Phaser54
from the Ccp4 suit was used to solve the structures. OmpK36 (ID PDB: 1OSM) was
used as search model to solve Omp36 structure, while OmpF (ID PDB: 2OMF) was
used  as  search  model  to  solve  Omp35.  The  structures  were  built  manually  using
Coot51 and refined using Refmac550. Data quality was checked with Molprobity55. The
data  collection  and  refinement  statistics  for  all  the  proteins  are  summarised  in
Supplementary Table 6.
Selectivity and conductance measurements
The method of multi-channel measurements for the selectivity characterisation has
been described  in  detailed  in  previous  publication  38,56.  Briefly,  a  Teflon  chamber
composes the system with two compartments separated by a thin wall. A circular hole
with  an  area  of  1  mm2 located  on  this  wall  were  painted  by  1% (w/v)  DPhPC
dissolved in n-decane. Membrane formation was monitored under a microscope with
light  reflection,  which  turned  optically  black  gradually  indicating  the  bilayer
formation.
In  all  the  experiments  1,2-diphytanoly-snglycero-3-phosphocholine  (DPhPC)  from
Avanti  polar  lipids,  Inc.  was  used.  Chloroform,  4-(2-hydroxyethyl)-1-
piperazineethanesulfonic  acid (HEPES),  and  Potassium  hydroxide  (KOH)  were
obtained  from Carl  Roth  GmbH.  Potassium chloride  (KCl)  and  2-(N-morpholino)
ethanesulfonic acid (MES) polyamine spermine were obtained from Sigma-Aldrich.
Octyl-Polyethylene  glycol  octyl  ether  (Octyl-POE)  was  obtained  from Enzo  Life
Science.
The actual selectivity was recorded by application of a tenfold gradient in KCl alone
(0.1 vs. 1 M KCl). The zero current voltage was recorded using  standard Ag/AgCl
electrodes with a salt bridge.
The methods of single channel measurements were carried out on the MECA (Multi-
electrode  cavity  array)  chips  (Ionera  Technologies  GmbH)  using  DPhPC  as
previously described by Baaken G. et al.57. 16 cavities each with diameter Ø50 µm are
located on the MECA chip. Each cavity was painted automatically to form individual
bilayers.  The  cavities  are  connected  to  the  headstage  of  amplifier  (Axon  200B,
Molecular Devices) from the bottom (trans) and face a common bath solution, which
is connected to the ground (cis). Briefly, 0.3 µL of 0.1 mg/ml DPhPC lipids dissolved
in  octane  were  added  onto  the  MECA  chip  mounted  in  Orbit  16  (Nanion
Technologies GmbH), without pre-treating the cavities with additional solvent. The
planar lipid bilayers were formed in an automated fashion by controlling a Teflon
coated  magnetic  bar,  this  process  was  computer  controlled  by  the  OrbitControl
software (Nanion Technologies GmbH). 
After  successful  single  channel  reconstitution,  the  cis side  of  the  chamber  was
manually  perfused  carefully  to  remove  extra  proteins  in  order  to  prevent  further
protein insertions. Single channel current measurements were digitized by a Digidata
1440 digitizer  (Molecular  Devices) and amplified by an Axopatch 200B amplifier
(Molecular Devices) recorded in the voltage clamp mode through PClamp software
(Molecular  Devices).  Signals  were  filtered  by  a  low-pass  Bessel  filter  at  10  kHz
acquired with a sampling rate at 50 kHz. The current amplitude and noise analysis
were performed using Clampfit 10.8 (Molecular Devices). The measured parameters
were the frequency of current transient spikes (ν (s-1)) and averaged residence time (τ).).
The averaged residence time was calculated from exponential  fit of total residence
time measured from each transient spike recorded over the entire time scale. External
transmembrane  potentials  were  applied  from  the  trans side,  continuous  constant
voltages were applied for at least 60 sec to collect sufficient stochastic events. Hidden
Markov Model was applied to investigate the substrate-protein interaction, which is
considered  as  a  one-binding  site-two-barrier  model.  When  same  substrates  were
added from  cis side only, two kinetic rates were obtained, i.e. association rate (kon)
and dissociation rate  (koff).  The association rate,  kon, is  calculated from the current
transient spike frequency,
kon = v3[c] , where [c] is the concentration at  cis side. It is
independent  to  the  substrate  concentration  and  determines  the  flux  through  each
monomer (porins are composed with three identical monomers) when saturation does
not occur.  The dissociation rate,
koff =1t ,  is inversely proportional to the residence
time (τ).).
Antibiotic list
Carbapenems including ertapenem (ETP), meropenem (MEM) and imipenem (IPM)
were  purchased  from  Sequoia  Research  Products  Ltd.  (United  Kingdom);
cephalosporins including ceftazidime (CAZ), cefepime (FEP), cefotaxime (CTX) and
penicillins including piperacillin (PIP) and ticarcillin (TIC) were from Sigma. 
Liposome swelling assay
The  liposome  suspension  mixture  was  prepared  by  mixing  100  mg  egg
phosphatidycholine (solubilized in 25 mg/ml in chloroform; Avanti Polar Lipids)
and  2.3  mg  dihexadecyl  phosphate  (dissolved  in  1  ml  of  chloroform).  For  each
protein,  100  μg/mL) for overnightl  from  the  liposome  suspension  was  aliquoted  in  glass  tubes  and
vacuum dried for 2 hours. The thin dried lipid layer was then solubilized in 100 μg/mL) for overnightl
water along with the addition of required protein amount, such that all proteins
have the same molar amount in each experiment set-up. This mixture
was sonicated  for  2  min  before  leaving for  drying overnight  in  a  desiccator.  The
control liposome mixture was prepared by adding buffer instead of protein into the
liposome suspension. Next day, 200 ml of 12mM of stachyose solution (in 10mM
HEPES, pH 7.0) was added to the overnight dried proteolipid film and mixed gently
before  proceeding  to  the  swelling  assay.  For  each  assay,  5  μg/mL) for overnightl  of  proteoliposome
mixture was added to 100 μg/mL) for overnightl of substrate solution.
The substrate concentration for  each compound was determined
empirically,  so  that  no  changes  in  optical  density  occur  when
measured  with  the  control  protein-free  liposomes.  Substrate
addition was followed by rapid mixing before monitoring the optical
density  at  400  nm  for  60  sec  at  a  5  sec  interval  (dead  time
experiment: ~ 5 s). The swelling assay rate for glycine permeation
through  OmpF of  E.  coli was  taken as  100% (as  reference)  for
calculating  the  other  permeation  rates.  To  ensure  equimolar
amounts of proteins, 15µg for a protein with the molecular weight
of 25 kDa was set as the standard to calculate the amounts of each
protein  needed  for  the  assays.  The  concentrations  used  were:
glycine 10-12 mM, glucose 10-12 mM, arginine 8 mM, glutamate
10 mM, ampicillin   8  mM, meropenem 8-9  mM, imipenem   9-10
mM,  ceftazidime  10  mM,  ertapenem  12  mM,  cefepime  2  mM,
cefotaxime  9-10  mM,  ticarcillin  8  mM,  piperacillin  10  mM.  The
empirically  determined  concentrations  of  certain  substrates
changed slightly for different liposome preparations.
Molecular dynamics
All  6 X-ray structures  (Omp35,  Omp36,  OmpE35, OmpE36,  OmpK35, OmpK36)
were used as starting coordinates for molecular dynamics (MD) simulations. All the
amino acid residues were simulated in their ionization state at neutral pH except for
E296  (OmpF),  D299 (OmpC),  E102 (Omp35),  D307 (Omp36),  E102 (OmpK35),
D297 (OmpK36), which were protonated (net charge 0), in all the three monomers for
each trimmer, as suggested for OmpF by Varma et al. 58 .
For  each  porin,  the  entire  trimer  was  embedded  in  a  pre-equilibrated  POPC (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) bilayer of 259 lipids and the system
was oriented in order to center the protein at the origin of the coordinate system and
align  the  channel  along  the  z-axis  (positive  z:  extracellular  side;  negative  z:
periplasmic side). Each system was solvated in a 200mM KCl solution. Only the last
600 ns were used for the analysis
After 1 ps of energy minimization (conjugate gradients), a slow heating from 10 to
300 K was carried out for 1ns. During this stage, positional restraints were applied on
the  protein  cα-carbons  (along  all  three  dimensions),  as  well  as  on  the  lipids
phosphorus atoms (along z only). After releasing the constraints  on the POPC, an
equilibration  stage  follows  for  4  ns  in  the  NPT ensemble  at  1.0  bar  and 300 K.
Finally,  700  ns  MD simulations  were  performed  in  the  NVT ensemble  after  the
elimination of the protein restraints. 
The NPT equilibration was performed with the program NAMD59, with 1.0 fs time-
step, and treating long-range electrostatics with the soft particle mesh Ewald (SPME)
method (64 grid points and order 4 with direct cutoff at 1.0 nm and 1.0 Å grid-size).
Pressure control was applied using the Nose-Hoover method (extended Lagrangian)
with isotropic  cell,  integrated  with the Langevin  Dynamics  (200 fs  and 100 fs  of
piston period and decay, respectively).  The latter  was also applied for temperature
control with 200 fs thermostat damping time. Production runs in the NVT ensemble
were performed with the ACEMD60 code compiled for GPUs, by rescaling hydrogen
mass to 4 au and increasing the time-step up to 4.0 fs. The Langevin thermostat was
used with 1 ps damping time. SPME was used to treat the electrostatics as for the
equilibration stage. The Amber99SB-ILDN force field was used for the protein and
lipids, and the TIP3P for waters. For all the known-antibiotics the Gaff-force field
parameters  where  obtained  from  http://www.dsf.unica.it/~gmalloci/abdb/.  All
molecular  properties where calculated from a 1 µs trajectory of the molecule in a
0.1M KCl solution61. In the case of the three primary amines and their derivatives10 we
used  the  ChemAxon’s  Marvin  suite  of  programs62 to  draw  the  structure  and
calculate the dominant tautomer distribution for each molecule and thus find the
protonation/charge states most populated at physiological pH = 7.4. Atomic partial
charges were then generated through the two-step restrained electrostatic potential
(RESP) method63 implemented in the Antechamber package64.  
Scoring function: derivation and calculation protocol
The antibiotic  translocation process can be treated as a one-dimensional diffusion-
drift problem 36,38. Under this assumption, the channel permeability coefficient reads:
P = exp(U(Z) / kBT)D(Z) dZ0
Lò
é
ëê
ù
ûú
- 1
(1)
where U(Z) is the potential of mean force and D(Z) is the diffusion coefficient along
the  pore  axis  (Z);  L  is  the  length  of  the  pore  and  kBT  is  the  thermodynamic
temperature. Although the diffusion model of Eq. 1 is governed by an integral of the
free-energy profile U(Z) along the whole length L of the pore, the largest contribution
comes from the free-energy barrier region,  i.e. the CR. Hence, the integral in Eq. 1
can be approximated to the value of the integrand in the CR only, multiplied by, the
length of the CR (ΔL). Therefore, the simplified equation for the permeability reads:
P =Deff
DL e
- 1kBT
UCR
 (2),
where Deff is the effective diffusion constant in the CR and UCR is the free-energy
barrier for the substrate in the CR. Within this approximation, the logarithm of the
permeability coefficient can be directly connected to the free-energy barrier in CR,
ln(P)=- 1kBT
UCR + ln
Deff
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. Due to, (i) the weak logarithmic dependence of ln(P) on
Deff and ΔL,  and (ii)  the  expected  small  variation  of  the  two parameters,  we can
assume that  the second term is  the same for all  substrates in all  pores.  The latter
assumption is due to the fact that the length of the CR (ΔL) is almost the same for all
the pores considered. Moreover, the diffusion constant depends on the viscosity of the
media and the radius of molecules (Supplementary Table 2), which does not vary
more than 15% for small molecules. Hence, 
ln(P)=- 1kBT
UCR +const
(3)
All the parameters included in the scoring function (Eq.1) were calculated from all-
atom  MD  simulations.  The  geometric  cross-section  area  was  calculated
superimposing a grid onto each monomer of the trimmers and mapping for each frame
all the protein atoms with their respective van-der-Waals radii. For each Z value, we
sum the number of empty points of the grid to obtain the cross-section area at that
particular Z and time. The internal electric field was calculated following the protocol
in 28. In the scoring function only the block average of the electric field in the CR is
considered.  The  electrostatic  potential  was  calculated  by  integrating  the  internal
electric field along the waters putative path along the diffusion axis of the channel; its
block average value in the CR is used for the scoring function.
Molecular  properties  were  also  calculated  from  all-atom  MD  trajectories  of  the
molecule  in  a  0.1MKCl  solution.  Minimal  projection  areas  were  taken  from
http://www.dsf.unica.it/~gmalloci/abdb for  the  available  molecules.  For  the  new
molecules  from  10,  the minimal  projection  area  was calculated  with the molecular
descriptors  plugin  of  Marvin  62.  All  dipole  moments  were  calculated  with  Dipole
Moment Watcher plugin of VMD 65.
In  order  to  test  the  dependence  of  the  permeability  results  on  the  different  terms
scoring function we repeated the fitting procedure, using different combinations of the
three  terms  of  Eq.1,  (Supplementary  Figure  4).  The  entropic  term  (Usteric)  only,
correlates poorly with the measured permeability (r=0.55, Supplementary Figure 4a),
as does the size difference, Sm-Sp (Supplementary Figure 4b, r=0.59, RMSE=0.72).
Considering only the electrostatic potential term gives a higher correlation than either
size difference or entropic term (r=0.7 Supplementary Figure 4c). Regarding the use
of the electric field term, a hypothetical perfectly aligned molecule in the CR using
the averaged total dipole of the molecule DmEpt, yields a weak correlation (r=0.15,
Supplementary Figure 4d). However, if the transverse component to the main axis of
inertia of the molecule is considered the correlation improves (r=0.56, RMSE=0.74,
Supplementary  Figure  4e).  Combining  the  two  electrostatic  terms  we  obtain  a
correlation of r=0.81 (RMSE=0.52) (Supplementary Figure 4f). The combination of
the first  three terms (Usteric+ QmVp+ DxymEpt) plus the constant shift  (δ) gives a very
reliable  correlation  coefficient  r=0.86  (RMSE=0.47).  On  the  other  hand,  using  a
different shift  term for each pore,  which implies that glycine can have a different
permeability  through  the  different  pores,  does  not  significantly  improve  the
correlation coefficient (r=0.88, RMSE=0.44), supporting our initial assumption.
Antibacterial  activity  and  whole-cells-based  assays  to  evaluate  β-lactam  flux
through porins. 
Cultures  of  E.  coli K12ΔFC expressing  the  different  porin  orthologues  were
challenged with cefepime or ceftazidime at a fixed concentration that equals 2  MIC
for  the  hypersusceptible  wild-type  K12  (i.e. cefepime,  MIC  of  0.06  µg/ml;
ceftazidime, MIC of 0.125 µg/ml).  CFU counts were determined by plating on MH
agar and plotted as mean values of % CFU decrease in the presence and absence of
antibiotics over time (Supplementary Figure 7). All assays were performed in E. coli
K12  strain  W3110  and  derivative  porin  mutants  of  (i.e. ΔompC,  ΔompF and
ΔompCΔompF, herein referred to as K12ΔC, K12ΔF and K12ΔFC). The role of  E.
coli OmpF and OmpC was assayed in K12ΔC, K12ΔF and in K12ΔFC as a control
porin-less  strain. The  role  of  OmpF  and  OmpC  orthologs  was  investigated  in
K12ΔFC transformed  with  either  the  empty  vectors  pBAD24  or  pB22  or  the
recombinant  plasmids  containing  E.  aerogenes  omp35,  omp36 (pBAD24-omp35,
pBAD24-omp36);  E.  cloacae  ompE35,  ompE36 (pBAD24-ompE35,  pBAD24-
ompE36); and K. pneumoniae (pB22-ompK35, pBAD24-ompK36). Strains containing
pBAD24  or  pB22  derivative  plasmids  were  cultured  in  Mueller  Hinton  II  Broth
(MHIIB)  in  the  presence  of  ampicillin  (100  µg/ml)  and  protein  expression  was
induced with 0.1% L-arabinose (Sigma) for 2 h at 37°C. Of note, E. coli K12 was used
instead  BL21  because  it  expresses  the  arabinose  transporter  AraE  that  ensures
uniform uptake of arabinose and expression of proteins cloned under the control of an
arabinose-inducible promoter. When tested for β-lactam permeability, cultures were
diluted  to  107 cells/ml  in  fresh  MHIIB  supplemented  with  0.1%  L-arabinose,  β-
lactamase  inhibitors  tazobactam and clavulanic  acid  (4  µg/ml  each)  to  inhibit  the
activity  of  the  plasmid-borne  AmpC66, and  in  the  presence  or  in  the  absence  of
antibiotics. Minimum inhibitory concentrations (MICs) were determined for the K12
wild-type and K12ΔFC strains by using 96-well microtiter plates and a standard 2-
fold microdilution method in MHIIB. Approximately 2105 cells were inoculated and
results were read after incubation at 37°C for 18 h. For time killing assays, cells (10
ml) were prepared as described above and exposed to FEP or CAZ added at a final
concentration of 2  MIC of the K12 wild-type strain (i.e. FEP, 0.125 µg/ml; CAZ,
0.25 µg/ml). Series of 10-fold dilutions were prepared in non-supplemented MHIIB
every 30 min for 180 min and spread on MH agar plates containing ampicillin. Plates
were incubated at 37°C for 18 h and colonies were manually counted. Colony forming
units (CFU/ml) were calculated for each time point and plotted as the % decrease in
CFU/ml in the presence as compared to in the absence of antibiotic.
omp35 and omp36 were PCR-amplified from a colony of E. aerogenes ATCC15038
by using specific primer pairs:
35-Fd  5'-GGAGGAATTCACCATGGTGAAGCGCAATATTCTGGCAGT-3'  and 
35-Rv 5'-CAGGTCGACTCTAGATTAGAACTGGTAAACGATACCAACC-3',  and
36-Fd  5'-GGAGGAATTCACCATGGAAGTTAAAGTACTGTCCCTCCTG-3’  and
36-Rv  5'-CAGGTCGACTCTAGATTAGAACTGGTAAACCAGGCC-3',
respectively. PCR products were cloned under the pBAD promoter into the pBAD24
vector between the NcoI and XbaI restriction sites by using the InFusion cloning kit
(Takara Bio USA Inc) according to the manufacturer instruction.
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